The pervasive impact of frailty on ovarian cancer care and the role of prehabilitation: Qualitative perspectives of key stakeholders. Read more about The pervasive impact of frailty on ovarian cancer care and the role of prehabilitation: Qualitative perspectives of key stakeholders.
Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adults. Read more about Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adults.
Education, incident cancer, and rate of memory decline in a national sample of US adults in mid-to-later-life. Read more about Education, incident cancer, and rate of memory decline in a national sample of US adults in mid-to-later-life.
Change in four measures of physical function among older adults during lung cancer treatment: A mixed methods cohort study. Read more about Change in four measures of physical function among older adults during lung cancer treatment: A mixed methods cohort study.
Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study. Read more about Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study.
Geriatric assessment in adults age 50 years and older undergoing autologous hematopoietic cell transplantation for lymphoma. Read more about Geriatric assessment in adults age 50 years and older undergoing autologous hematopoietic cell transplantation for lymphoma.
Decision-making about clinical trial options among older patients with metastatic cancer who have exhausted standard therapies. Read more about Decision-making about clinical trial options among older patients with metastatic cancer who have exhausted standard therapies.
"You have to be sure that the patient has the full picture": Adaptation of the Best Case/Worst Case communication tool for geriatric oncology. Read more about "You have to be sure that the patient has the full picture": Adaptation of the Best Case/Worst Case communication tool for geriatric oncology.
Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis. Read more about Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis.
Does the cancer geriatric assessment (GA) introduce bias into clinical trials? Observations from 988 prospectively recruited patients. Read more about Does the cancer geriatric assessment (GA) introduce bias into clinical trials? Observations from 988 prospectively recruited patients.
